Dec 3 – The science (and stigma) of Suboxone, or buprenorphine, a drug used to treat opioid addiction is making headlines across the news blogosphere, following a series in The New York Times.

The local view is reported by Portland Business Journal’s Elizabeth Hayes, in the multi-part series on addiction and its costs. (Quoted in this installment is CODA Medical Director Melissa Weimer, DO, MCR.)

The NYT series by reporter Deborah Sontag has led to opinion columns from many corners, including a much-tweeted, Facebook-ed and emailed piece on Huffington Post by Aaron Fox and Chinazo Cunningham.